1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics, November 2016 (p50)

Biotechnology Analysis & Statistics, November 2016 (p50)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1471-1500 of about 4800 reports

Purchase Reports From Reputable Market Research Publishers

Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)

Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)

  • $ 800
  • Industry report
  • November 2016
  • by Daedal Research

Scope of the Report The report entitled “Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)”, provides an analysis of global biosimilar market in terms of value. The report also provides ...

  • Industries : Biopharmaceutical, Pharmaceutical, Generic Drug, Biotechnology
  • Countries : World
Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)

Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)

  • $ 900
  • Industry report
  • November 2016
  • by Daedal Research

Scope of the Report The report titled “Global Allergy Immunotherapy Market: Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global allergy immunotherapy market by value, ...

  • Industries : Biological Therapy
  • Countries : World
Biosimilars Education: Addressing a significant unmet need

Biosimilars Education: Addressing a significant unmet need

  • $ 2448
  • Industry report
  • November 2016
  • by Firstword Pharma

How to educate stakeholders about biosimilar benefits What information and data do physicians, payers and patients need about biosimilars? As the market expands and new therapeutic sectors come on stream, ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : Europe, United States
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion ...

  • Industries : Pathology, Therapy, Biological Therapy, Pharmaceutical
  • Countries : United States, World
Beijing Tiantan Biologic.

Beijing Tiantan Biologic.

  • $ 99
  • Company report
  • October 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Beijing Tiantan Biologic. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Countries : China
Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H2 2016

Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Human cytomegalovirus 65 kDa Phosphoprotein (PP65 or 65 kDa Matrix Phosphoprotein or Tegument Protein UL83 or UL83) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human cytomegalovirus ...

  • Industries : Pathology
  • Countries : World, United States
Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H2 2016

Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP) - Pipeline Review, H2 2016

P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein or CD62P or SELP) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

P Selectin (CD62 Antigen Like Family Member P or Granule Membrane Protein 140 or Leukocyte Endothelial Cell Adhesion Molecule 3 or LECAM3 or Platelet Activation Dependent Granule External Membrane Protein ...

  • Industries : Therapy, Pathology, Pharmaceutical, Cancer, Health Facility
  • Countries : United States
Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Pipeline Review, H2 2016

Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Pipeline Review, H2 2016 Summary ...

  • Industries : Biopharmaceutical, Cancer
  • Countries : World
Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) - Pipeline Review, H2 2016

Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Therapy, Pathology, Chronic Disease, Pharmaceutical, Biopharmaceutical
  • Countries : United States, World
CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2016

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Biological Therapy, Cancer, Pathology, Oncology
  • Countries : United States
Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Telomerase Reverse Transcriptase (HEST2 or Telomerase Catalytic Subunit or Telomerase Associated Protein 2 or TERT or EC 2.7.7.49) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Telomerase ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States, World
Cirrhosis Global Clinical Trials Review, H2, 2016

Cirrhosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Cirrhosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Cirrhosis Global Clinical Trials Review, H2, 2016" provides an overview of Cirrhosis clinical trials scenario. ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy
  • Countries : World
Interleukin 13 (IL13) - Pipeline Review, H2 2016

Interleukin 13 (IL13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Interleukin 13 (IL13) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted ...

  • Industries : Therapy, Pathology, Chronic Disease, Biological Therapy
  • Countries : United States
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 6 (Protein Phosphatase 1 ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • October 2016
  • by Global Markets Direct

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘T Cell Surface Glycoprotein CD3 Epsilon ...

  • Industries : Therapy, Oncology, Chronic Disease, Pathology
  • Countries : World, United States, Europe
Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016

Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016" provides an overview of Alcoholic ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : World
Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016

Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World
Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2016

Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Abdominal Aortic Aneurysms Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : World
Synovial Sarcoma Global Clinical Trials Review, H2, 2016

Synovial Sarcoma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Synovial Sarcoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Synovial Sarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Synovial Sarcoma ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World
Reperfusion Injury Global Clinical Trials Review, H2, 2016

Reperfusion Injury Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Reperfusion Injury Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Reperfusion Injury Global Clinical Trials Review, H2, 2016" provides an overview of Reperfusion ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Hepatitis A - Pipeline Review, H2 2016

Hepatitis A - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis A - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A – Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology
  • Countries : World, China, India
Liposarcoma Global Clinical Trials Review, H2, 2016

Liposarcoma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Liposarcoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Liposarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Liposarcoma clinical trials ...

  • Industries : Cancer, Health Facility, Pathology, Therapy
  • Countries : World
Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016

Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : World
Angiosarcoma Global Clinical Trials Review, H2, 2016

Angiosarcoma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Angiosarcoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Angiosarcoma clinical trials ...

  • Industries : Cancer, Pathology, Therapy, Biological Therapy
  • Countries : World
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology, Therapy, Healthcare
  • Countries : World
Pediatric Cancer Global Clinical Trials Review, H2, 2016

Pediatric Cancer Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Pediatric Cancer Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Pediatric Cance ...

  • Industries : Cancer, Pathology, Therapy, Health Facility
  • Countries : World
Hematological Tumor Global Clinical Trials Review, H2, 2016

Hematological Tumor Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Hematological Tumor Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H2, 2016" provides an overview of Hematological ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World
Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • October 2016
  • by GlobalData

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World
Global Enzyme Standard Instrument Market Research Report 2016

Global Enzyme Standard Instrument Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Enzyme Standard Instrument Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Enzyme Standard Instrument industry, focusing ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe, Asia, North America
About 19000 reports

Download Unlimited Documents from Trusted Public Sources

Cell Therapy Industry in the Netherlands

  • February 2017
    82 pages
  • Cell Therapy  

    Tissue Engineer...  

  • Netherlands  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.